Searched for
ROCHE OBESITY DRUG TRIAL
Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'- Manipur CM says drug trafficking routes have changed after 2023 crisis, largely diverting through Mizoram
- India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug sales
- Alembic Pharma gets USFDA nod for generic influenza treatment drugAlembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...26 Jun, 2026, 02.50 PM IST
- Govt to amend NDPS Act to plug loopholes exploited by narco syndicates: Amit ShahUnion Home Minister Amit Shah announced plans to amend the NDPS Act to combat drug syndicates, emphasizing a strict approach against peddle...26 Jun, 2026, 01.49 PM IST
- 'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugsDespite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...26 Jun, 2026, 01.48 PM IST
- CDSCO asks states, port offices to step up screening to curb imports of illegal drugsIndia's drug regulator is intensifying border screenings to block unapproved medicines from entering the country. Authorities are cracking ...26 Jun, 2026, 10.08 AM IST
- Veteran sprinter Srabani's secret of longevity: Hunger for success, drugs-free bodyVeteran Indian sprinter Srabani Nanda, at 35, credits her enduring success and recent Asian Relays gold to unwavering hunger and a commitme...24 Jun, 2026, 12.42 PM IST
- AI Euphoria, Fed Signals and Oil Politics: David Roche warns markets may be ignoring bigger risksGlobal markets are optimistic about AI and easing inflation, but David Roche warns of deeper structural risks. He believes the AI investmen...19 Jun, 2026, 11.34 AM IST
- Pfizer CFO Dave Denton to leave company in AugustPfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...19 Jun, 2026, 12.13 AM IST
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...16 Jun, 2026, 06.27 PM IST
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...16 Jun, 2026, 02.24 PM IST
- Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...15 Jun, 2026, 04.40 PM IST
- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...15 Jun, 2026, 11.08 AM IST
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...12 Jun, 2026, 11.48 PM IST
- UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...12 Jun, 2026, 08.36 AM IST
- India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...12 Jun, 2026, 12.37 AM IST
- India's weight-loss market grows upThe landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...10 Jun, 2026, 11.28 PM IST
- US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...08 Jun, 2026, 10.14 PM IST
- Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefitsEli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...07 Jun, 2026, 06.51 AM IST
Load More
